vs
RYTHM, Inc.（RYM）与TRANSACT TECHNOLOGIES INC（TACT）财务数据对比。点击上方公司名可切换其他公司
TRANSACT TECHNOLOGIES INC的季度营收约是RYTHM, Inc.的1.1倍（$11.5M vs $10.7M），RYTHM, Inc.同比增速更快（242.0% vs 11.9%），过去两年RYTHM, Inc.的营收复合增速更高（102.6% vs 3.5%）
RYTHM Inc.是一家临床阶段生物制药企业，专注于研发和商业化针对罕见遗传性内分泌与代谢疾病的创新疗法，主要面向美国市场，服务存在未被满足医疗需求的儿童及成人患者群体。
该公司相关归属主体罗珀技术公司是一家控股集团，主要投资控股科技领域的各类企业，业务覆盖多个科技细分赛道，依托旗下子公司开展多元化科技业务布局。
RYM vs TACT — 直观对比
营收规模更大
TACT
是对方的1.1倍
$10.7M
营收增速更快
RYM
高出230.0%
11.9%
两年增速更快
RYM
近两年复合增速
3.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.7M | $11.5M |
| 净利润 | $-13.6M | — |
| 毛利率 | 75.5% | 47.6% |
| 营业利润率 | -121.5% | -10.1% |
| 净利率 | -127.6% | — |
| 营收同比 | 242.0% | 11.9% |
| 净利润同比 | 44.1% | — |
| 每股收益（稀释后） | $-6.78 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RYMTACT
| Q4 25 | $10.7M | $11.5M | ||
| Q3 25 | $4.0M | $13.2M | ||
| Q2 25 | $2.0M | $13.8M | ||
| Q1 25 | $538.0K | $13.1M | ||
| Q4 24 | $-7.5M | $10.2M | ||
| Q3 24 | $1.9M | $10.9M | ||
| Q2 24 | $3.0M | $11.6M | ||
| Q1 24 | $2.6M | $10.7M |
净利润RYMTACT
| Q4 25 | $-13.6M | — | ||
| Q3 25 | $-10.7M | $15.0K | ||
| Q2 25 | $-7.4M | $-143.0K | ||
| Q1 25 | $-1.6M | $19.0K | ||
| Q4 24 | $-24.4M | — | ||
| Q3 24 | $-18.7M | $-551.0K | ||
| Q2 24 | $-3.0M | $-319.0K | ||
| Q1 24 | $4.2M | $-1.0M |
毛利率RYMTACT
| Q4 25 | 75.5% | 47.6% | ||
| Q3 25 | 34.0% | 49.8% | ||
| Q2 25 | 33.4% | 48.2% | ||
| Q1 25 | 16.7% | 48.7% | ||
| Q4 24 | — | 44.2% | ||
| Q3 24 | 11.6% | 48.1% | ||
| Q2 24 | 37.6% | 52.7% | ||
| Q1 24 | 6.4% | 52.6% |
营业利润率RYMTACT
| Q4 25 | -121.5% | -10.1% | ||
| Q3 25 | -219.8% | 0.1% | ||
| Q2 25 | -332.9% | -1.9% | ||
| Q1 25 | -687.9% | -0.1% | ||
| Q4 24 | — | -10.3% | ||
| Q3 24 | -63.1% | -7.7% | ||
| Q2 24 | -28.5% | -3.8% | ||
| Q1 24 | 13.6% | -12.2% |
净利率RYMTACT
| Q4 25 | -127.6% | — | ||
| Q3 25 | -263.8% | 0.1% | ||
| Q2 25 | -360.4% | -1.0% | ||
| Q1 25 | -302.2% | 0.1% | ||
| Q4 24 | 324.4% | — | ||
| Q3 24 | -964.4% | -5.1% | ||
| Q2 24 | -99.3% | -2.8% | ||
| Q1 24 | 163.0% | -9.7% |
每股收益（稀释后）RYMTACT
| Q4 25 | $-6.78 | $-0.11 | ||
| Q3 25 | $-5.33 | $0.00 | ||
| Q2 25 | $-3.74 | $-0.01 | ||
| Q1 25 | $-0.83 | $0.00 | ||
| Q4 24 | $-24.26 | $-0.80 | ||
| Q3 24 | $-17.28 | $-0.06 | ||
| Q2 24 | $-3.16 | $-0.03 | ||
| Q1 24 | $3.78 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $32.2M | $20.4M |
| 总债务越低越好 | $80.6M | — |
| 股东权益账面价值 | $13.0M | $31.1M |
| 总资产 | $106.7M | $44.8M |
| 负债/权益比越低杠杆越低 | 6.19× | — |
8季度趋势，按日历期对齐
现金及短期投资RYMTACT
| Q4 25 | $32.2M | $20.4M | ||
| Q3 25 | — | $20.0M | ||
| Q2 25 | $41.0M | $17.7M | ||
| Q1 25 | $24.4M | $14.2M | ||
| Q4 24 | — | $14.4M | ||
| Q3 24 | $267.0K | $11.3M | ||
| Q2 24 | $57.0K | $11.1M | ||
| Q1 24 | $99.0K | $10.6M |
总债务RYMTACT
| Q4 25 | $80.6M | — | ||
| Q3 25 | $90.6M | — | ||
| Q2 25 | $40.6M | — | ||
| Q1 25 | $10.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $6.2M | — | ||
| Q2 24 | $4.6M | — | ||
| Q1 24 | — | — |
股东权益RYMTACT
| Q4 25 | $13.0M | $31.1M | ||
| Q3 25 | $11.7M | $31.8M | ||
| Q2 25 | $21.0M | $31.3M | ||
| Q1 25 | $26.8M | $30.9M | ||
| Q4 24 | $28.1M | $30.6M | ||
| Q3 24 | $5.5M | $38.4M | ||
| Q2 24 | $8.5M | $38.5M | ||
| Q1 24 | $-5.5M | $38.6M |
总资产RYMTACT
| Q4 25 | $106.7M | $44.8M | ||
| Q3 25 | $115.2M | $45.0M | ||
| Q2 25 | $69.5M | $44.5M | ||
| Q1 25 | $45.6M | $44.2M | ||
| Q4 24 | $54.0M | $44.0M | ||
| Q3 24 | $39.0M | $50.5M | ||
| Q2 24 | $39.4M | $50.4M | ||
| Q1 24 | $40.6M | $51.9M |
负债/权益比RYMTACT
| Q4 25 | 6.19× | — | ||
| Q3 25 | 7.73× | — | ||
| Q2 25 | 1.94× | — | ||
| Q1 25 | 0.40× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.13× | — | ||
| Q2 24 | 0.54× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.0M | $609.0K |
| 自由现金流经营现金流 - 资本支出 | — | $589.0K |
| 自由现金流率自由现金流/营收 | — | 5.1% |
| 资本支出强度资本支出/营收 | — | 0.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $7.6M |
8季度趋势，按日历期对齐
经营现金流RYMTACT
| Q4 25 | $-3.0M | $609.0K | ||
| Q3 25 | $-5.4M | $3.6M | ||
| Q2 25 | $-8.4M | $3.6M | ||
| Q1 25 | $-6.7M | $-161.0K | ||
| Q4 24 | $-5.3M | $2.4M | ||
| Q3 24 | $-1.4M | $327.0K | ||
| Q2 24 | $-1.8M | $636.0K | ||
| Q1 24 | $-3.0M | $-1.5M |
自由现金流RYMTACT
| Q4 25 | — | $589.0K | ||
| Q3 25 | — | $3.6M | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | — | $-171.0K | ||
| Q4 24 | — | $2.4M | ||
| Q3 24 | — | $259.0K | ||
| Q2 24 | $-1.8M | $499.0K | ||
| Q1 24 | $-3.0M | $-1.6M |
自由现金流率RYMTACT
| Q4 25 | — | 5.1% | ||
| Q3 25 | — | 27.1% | ||
| Q2 25 | — | 25.9% | ||
| Q1 25 | — | -1.3% | ||
| Q4 24 | — | 23.2% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | -61.2% | 4.3% | ||
| Q1 24 | -115.1% | -14.9% |
资本支出强度RYMTACT
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | 0.1% | 1.2% | ||
| Q1 24 | 0.1% | 1.0% |
现金转化率RYMTACT
| Q4 25 | — | — | ||
| Q3 25 | — | 242.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -8.47× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.71× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RYM
| Nonlicensing Revenue | $9.5M | 89% |
| Cultivation Business Discontinued Operations | $1.2M | 11% |
TACT
暂无分部数据
